These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34983359)

  • 21. Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System.
    Dittmar E; Wolfel T; Menendez L; Pozo J; Ramirez M; Belnap SC; De Los Rios La Rosa F
    Ann Pharmacother; 2023 Oct; 57(10):1147-1153. PubMed ID: 36688289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials.
    Bivard A; Huang X; McElduff P; Levi CR; Campbell BC; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Circulation; 2017 Jan; 135(5):440-448. PubMed ID: 27965285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke.
    Alamowitch S; Turc G; Palaiodimou L; Bivard A; Cameron A; De Marchis GM; Fromm A; Kõrv J; Roaldsen MB; Katsanos AH; Tsivgoulis G
    Eur Stroke J; 2023 Mar; 8(1):8-54. PubMed ID: 37021186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Zhao H; Alemseged F; Ng F; Bailey P; Rice H; de Villiers L; Dewey HM; Choi PMC; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Kraemer T; Krause M; Cordato D; Field D; Ma H; O'Brien B; Clissold B; Miteff F; Clissold A; Cloud GC; Bolitho LE; Bonavia L; Bhattacharya A; Wright A; Mamun A; O'Rourke F; Worthington J; Wong AA; Levi CR; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    JAMA; 2020 Apr; 323(13):1257-1265. PubMed ID: 32078683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials.
    Guillermin A; Yan DJ; Perrier A; Marti C
    Arch Med Sci; 2016 Dec; 12(6):1181-1187. PubMed ID: 27904506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials.
    Rehman AU; Mohsin A; Cheema HA; Zahid A; Ebaad Ur Rehman M; Ameer MZ; Ayyan M; Ehsan M; Shahid A; Aemaz Ur Rehman M; Shah J; Khawaja A
    J Neurol Sci; 2023 Feb; 445():120537. PubMed ID: 36630803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke.
    Alhadid K; Oliveira L; Etherton MR
    Curr Treat Options Cardiovasc Med; 2023; 25(1):15-28. PubMed ID: 36618509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
    Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
    Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol.
    Kawano H; Hirano T; Inoue M; Fukuda-Doi M; Iwasaki K; Omae K; Tanaka K; Yamamoto H; Koga M; Sakai N; Nagao T; Sasaki M; Hayakawa N; Toyoda K
    Eur Stroke J; 2022 Mar; 7(1):71-75. PubMed ID: 35300254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.
    Dundar Y; Hill R; Dickson R; Walley T
    QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
    Logallo N; Kvistad CE; Nacu A; Naess H; Waje-Andreassen U; Asmuss J; Aamodt AH; Lund C; Kurz MW; Rønning OM; Salvesen R; Idicula TT; Thomassen L
    BMC Neurol; 2014 May; 14():106. PubMed ID: 24886064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study.
    Dhar N; Kumar M; Tiwari A; Desai I; Madhaw G; Kumar N
    Ann Indian Acad Neurol; 2022; 25(5):897-901. PubMed ID: 36561006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
    Dunn CJ; Goa KL
    Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
    Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
    Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.